期刊文献+

氨基酸残基配型策略在高致敏尿毒症患者肾移植中的应用研究 被引量:3

APPLICATION OF HLA AMINO ACID RESIDUES MATCHING CRITERIA IN SENSITIZED URAEMIC RECIPIENTS
下载PDF
导出
摘要 目的:探讨人类白细胞抗原(HLA)氨基酸残基配型(Res M)标准在高致敏尿毒症患者肾移植中的应用。方法:在动态监测群体反应性抗体(PRA)水平、特异性及淋巴毒交叉配合试验的基础上,采用ResM标准选取与供者最匹配的供体。结果:56例尿毒症患者术前PRA均大于20%,采用Terasaki提出的ResM标准,供受者0抗原错配(MM)为6例(10.7%),1MM为13例(23.2%),2MM为19例(33.9%),3MM为13例(23.2%),4MM为5例(9.1%),5MM和6MM为0例。术后56例受者均未发生超急性排斥反应,17例(30.4%)发生急性排斥,经甲基强的松龙冲击治疗后3例(5.4%)切除移植肾,另14例(25%)排斥反应逆转,肾功能恢复。5例(8.9%)发生移植物功能延迟恢复(Delay Graft Function,DGF),经血液透析过渡治疗后均在5周内恢复。结论:Res M标准可提高PRA阳性受者与供者之间HLA相配程度,缩短患者等肾时间,降低排斥反应的发生率,是一种有效的、具有临床实用价值的配型策略。 Objective: To study the HLA amino acid residues matching criteria in kidney transplantation. Methods:The dynamic panel reactive autibody (PRA) levels and the specificity were determined. Res M was used to select the most appropriate donor. Results: The preoperative PRA levels in 56 recipients were higher than 20%. According to the Res M of Terasaki, the 0 to 6 antigen mismatched detail is as follows: 6(10. 7%), 13(23.2%), 19(33.9%), 13(23.2%), 5(9. 1%), 0 and 0. There was no hyper-aeute rejection detected among these 56 recipients. And 17 cases of acute rejection were detected. After concussion with radiosone, 5 transplanted kidneys were resected from 17 recipients. The others were reversed by the using of radiosone. Five recipients were got back by hemodialysis after the Delay Graft Function was detected, but they were both healed in 5 weeks. Conclusion: The HLA amino acid residues matching criteria is valuable and effectual in clinic by improving the matching rate, decreaseing time spending on waiting for donor and increasing using rate of organ.
出处 《广西医科大学学报》 CAS 2010年第3期394-396,共3页 Journal of Guangxi Medical University
基金 广西壮族自治区科技攻关项目(No.0719006-2-7 0993003D-17) 广西壮族自治区联合攻关及重大技术平台构建项目(No.08-42-01B)
关键词 肾移植 群体反应性抗体 人类白细胞抗原 氨基酸残基 kidney transplantation panel reactive antibodies human leukocyte antigen amino acid residue
  • 相关文献

参考文献7

  • 1Mason PM,Parham P.HLA class I region sequences,1998[J].Tissue Antigens,1998,51:417-466.
  • 2Terasaki pi,Cho Y,Takemoto S,et al.Twenty-yearfollow-upon the effect of HLA matching on kidney transpiant survival and prediction of furture twenty-year survival[J].Transplant Proc,1996,28(3):1 144-1 145.
  • 3Takemoto SK.HLA amino acid residue matching[J].Clin Transpl,1996,28(2):397-425.
  • 4Duquesnoy RJ,marrari M.Determination of HLA-A/B residue mismatch acceptability for kidneys transplanted into highly sensitized patients[J].Tansplantation,1997,63:1 743-1 751.
  • 5贾保祥,张玉海,田野,武俊杰,马威然.HLA氨基酸残基配型模式在肾移植中的研究[J].北京医学,2002,24(1):33-35. 被引量:3
  • 6Takemoto S,Cecka JM,Terasaki PI.Benefits of HLA-CREG matching for sensitized recipients as illustrated in kidney regraftes[J].Transplant Proc,1997,29(4):1 417-1 418.
  • 7Cole E,Naimark D,Aprile M,et al.An analysis for predictors of longterm cadaveric renal allograft survival[J].Clin Tansplan,1995,9:282-289.

二级参考文献5

  • 1Takemoto S,Terasaki PI.HLA compatibility can be predicted by matching only three residues with outward oriented sidechains.Transplant Proc,1996,28:1264~1266.
  • 2Mason PM,Parham P.HLA class I region sequences.Tissue Antigens,1998,51:417~466.
  • 3Mason SGE.HLA class II region sequences.Tissue Antigens,1998,51:467~507.
  • 4Takemoto SK,Cecka JM,Terasaki PI.Benefits of HLA-CREG matching for sensitized recipients as illustrated in kidney regrafts.Transplant Proc.1997,29:1417~1421.
  • 5Duquesnoy RJ,Marrari M.Determiantion of HLA-A/B residue mismatch acceptability for kidneys transplanted into highly sensitized patients.Transplantation,1997,63:1743~1751.

共引文献2

同被引文献60

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部